NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 8.92% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.32% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 6.72% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.64% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.39% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.39% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.22% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 4.17% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.77% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.74% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.37% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.27% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.02% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.97% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.52% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.48% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.43% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.81% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.71% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.37% |